SR 202

Discontinued Product

2022 has been discontinued.

View all PPARγ products.
Description: Selective PPARγ antagonist; antidiabetic and antiobesity agent
Alternative Names: Mifobate
Chemical Name: (4-Chlorophenyl)(dimethoxyphosphinyl)methyl phosphoric acid dimethyl ester
Purity: ≥99% (HPLC)
Datasheet
Citations
Reviews

Biological Activity for SR 202

SR 202 is a selective PPARγ antagonist; antidiabetic and antiobesity agent. Attenuates troglitazone-induced PPARγ transcriptional activity (IC50 = 140 μM) without affecting ligand-stimulated PPARα, PPARβ or FXR transcriptional activity. Inhibits PPARγ-dependent adipocyte differentiation and growth in vitro and in vivo. Improves insulin sensitivity in diabetic ob/ob mice and increases HDL levels in rats in vivo.

Technical Data for SR 202

M. Wt 358.65
Formula C11H17ClO7P2
Storage Desiccate at RT
Purity ≥99% (HPLC)
CAS Number 76541-72-5
PubChem ID 60910
InChI Key VQHUQHAPWMNBLP-UHFFFAOYSA-N
Smiles COP(=O)(OC)OC(C1=CC=C(Cl)C=C1)P(=O)(OC)OC

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.

Tocris products are intended for laboratory research use only, unless stated otherwise.

References for SR 202

References are publications that support the biological activity of the product.

Nguyen et al (1987) gem-Diphosphonate and gem-phosphonate-phosphate compounds with specific high density lipoprotein inducing activity. J.Med.Chem. 30 1426 PMID: 3612689

Rieusset et al (2002) A new selective peroxisome proliferator-activated receptor γ antagonist with antiobesity and antidiabetic activity. Mol.Endocrinol. 16 2628 PMID: 12403851

Doggrell (2003) Do peroxisome proliferation receptor-γ antagonists have clinical potential as combined antiobesity and antidiabetic drugs? Expert.Opin.Invest.Drugs 12 713

View Related Products by Target

View Related Products by Product Action

View all PPARγ Antagonists

Keywords: SR 202, SR 202 supplier, Selective, PPARγ, PPARgamma, antagonists, antidiabetic, antiobesity, agent, Peroxisome, Proliferator-activating, Receptors, SR202, Mifobate, 2022, Tocris Bioscience

Citations for SR 202

Citations are publications that use Tocris products.

Currently there are no citations for SR 202.

Reviews for SR 202

There are currently no reviews for this product. Be the first to review SR 202 and earn rewards!

Have you used SR 202?

Submit a review and receive an Amazon gift card.

$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image

$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image

Submit a Review